Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Glucagon Like Peptide 2 Receptor (GLP2R) - Overview
Glucagon Like Peptide 2 Receptor (GLP2R) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Glucagon Like Peptide 2 Receptor (GLP2R) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Glucagon Like Peptide 2 Receptor (GLP2R) - Companies Involved in Therapeutics Development
Glucagon Like Peptide 2 Receptor (GLP2R) - Drug Profiles
Glucagon Like Peptide 2 Receptor (GLP2R) - Dormant Products
Glucagon Like Peptide 2 Receptor (GLP2R) - Discontinued Products
Glucagon Like Peptide 2 Receptor (GLP2R) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development by Stage of Development, 2022
Number of Products under Development by Therapy Areas, 2022
Number of Products under Development by Top 10 Indications, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development by Stage of Development, 2022
Number of Products under Development by Therapy Areas, 2022
Number of Products under Development by Indication, 2022
Number of Products under Development by Companies, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Number of Products under Investigation by Universities/Institutes, 2022
Products under Investigation by Universities/Institutes, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Pipeline by 9 Meters Biopharma Inc, 2022
Pipeline by Amogen Pharma Pvt Ltd, 2022
Pipeline by Applied Molecular Transport Inc, 2022
Pipeline by Bainan Biotech ApS, 2022
Pipeline by Entera Bio Ltd, 2022
Pipeline by Hanmi Pharmaceuticals Co Ltd, 2022
Pipeline by Huons Global Co Ltd, 2022
Pipeline by OPKO Health Inc, 2022
Pipeline by Peg-Bio BioPharma Co Ltd, 2022
Pipeline by PhaseBio Pharmaceuticals Inc, 2022
Pipeline by Sosei Group Corp, 2022
Pipeline by Takeda Pharmaceutical Co Ltd, 2022
Pipeline by Tasly Pharmaceutical Group Co Ltd, 2022
Pipeline by VectivBio Holding AG, 2022
Pipeline by Zealand Pharma AS, 2022
Dormant Products, 2022
Dormant Products, 2022 (Contd..1)
Discontinued Products, 2022